IRIS
GAMBA, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.046
EU - Europa 1.549
AS - Asia 1.184
AF - Africa 10
OC - Oceania 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.803
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.029
CN - Cina 1.050
IE - Irlanda 439
UA - Ucraina 313
FI - Finlandia 238
DE - Germania 162
IT - Italia 116
SE - Svezia 113
SG - Singapore 102
GB - Regno Unito 81
FR - Francia 27
BE - Belgio 17
PL - Polonia 15
CA - Canada 14
IR - Iran 11
IN - India 8
MU - Mauritius 8
AU - Australia 5
NL - Olanda 5
RU - Federazione Russa 5
BR - Brasile 4
CH - Svizzera 4
CZ - Repubblica Ceca 3
MX - Messico 3
AT - Austria 2
DK - Danimarca 2
EG - Egitto 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
ID - Indonesia 2
RO - Romania 2
TH - Thailandia 2
TR - Turchia 2
AM - Armenia 1
BD - Bangladesh 1
CL - Cile 1
HK - Hong Kong 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SM - San Marino 1
VN - Vietnam 1
Totale 4.803
Salva come PNG Salva come JPEG
Città #
Dublin 437
Chandler 431
Jacksonville 404
Nanjing 321
Boardman 145
Ashburn 122
Nanchang 117
Shenyang 91
Lawrence 89
Princeton 89
Hebei 86
Wilmington 85
Changsha 84
Jiaxing 75
Singapore 71
Beijing 70
Helsinki 67
Medford 61
Ann Arbor 59
Tianjin 55
Hangzhou 46
Woodbridge 34
Milan 23
Des Moines 20
Shanghai 18
Brussels 17
Verona 17
Radomsko 14
Jinan 13
Kunming 13
Seattle 12
Toronto 12
Norwalk 11
Taizhou 10
Fairfield 9
Houston 9
Leawood 9
San Francisco 9
Los Angeles 8
Ningbo 8
Dearborn 7
New York 7
Auburn Hills 6
Fuzhou 6
Guangzhou 6
Falls Church 5
Zanjan 5
Zhengzhou 5
Chicago 4
Pavia 4
Rome 4
Washington 4
Ardabil 3
Bern 3
Ceska 3
Lanzhou 3
London 3
Monmouth Junction 3
Pune 3
Sydney 3
Zapopan 3
Bangkok 2
Barcelona 2
Bari 2
Bologna 2
Borås 2
Cairo 2
Caserta 2
Florence 2
Frankfurt am Main 2
Genova 2
Las Vegas 2
Lecco 2
Mumbai 2
Napoli 2
Orange 2
Paris 2
Piscataway 2
Poggibonsi 2
Pontedassio 2
Sacramento 2
Shaoxing 2
São Paulo 2
Tappahannock 2
Vienna 2
Alexandria 1
Almere Stad 1
Andover 1
Athens 1
Auckland 1
Belfast 1
Bellinzona 1
Berlin 1
Boston 1
Buffalo 1
Carcare 1
Changchun 1
Changzhou 1
Cork 1
Dallas 1
Totale 3.424
Salva come PNG Salva come JPEG
Nome #
Screening dei difetti dell'emostasi con Platelet Function Analyzer (PFA-100) in donne con meno-metrorragia 114
Coagulation-factor deficiencies and abnormal bleeding in Noonan’s syndrome 90
L'artropatia e l'emartro ricorrente nelle coagulopatie congenite: l'influenza del trattamento. 88
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 85
Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study. 84
Caratteristiche dell'emartro ed evoluzione in artropatia nelle coagulopatie congenite: osservazione su 145 casi afferenti al centro emofilia di Pavia 82
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 82
Atherosclerosis, vascular damage, thrombotic risk factors and congenital bleeding disorders 77
Acquired von Willebrand syndrome and monoclonal gammopathy: clinical characterization and recovery to infusion of VWF-containing concentrates 74
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 73
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 73
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 71
Clotting alterations in primary systemic amyloidosis. 68
Bleeding disorders in children with reccurent tonsillitis and prolonged aPTT 67
L'artropatia e l'emartro nelle coagulopatie congenite: l'influenza del trattamento 67
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 66
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 66
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 65
An unconventional case of scurvy. 65
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 64
Efficacy and safety of high doses of FEIBA for major surgery in a patient with haemophilia A and high titre inhibitor 63
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. 63
Liver damage and homocysteine plasma levels in haemophilia 62
Vascular damage, prothrombotic risk factor and trombosis in patients with inherited bleeding disorders 62
Desmopressin and platelets: In vitro and in vivo studies 62
Long-term evaluation of synovectomy and synoviorthesis on the evolution of joint damage: what's happened after 30 years of follow up? 62
Platelet-independent defect in hemostasis associated with sirolimus use 62
In vitro and in vivo effects of desmopressin on platelet function 62
Cardiovascular disease, hyperhomocysteinemia and atherothrombotic risk factors in psoriatic patients 61
Patterns of bleeding,comorbidities, and clinical courses in acquired hemophilia A (AHA) and in acquired von Willebrand disease (AVWD): Experience from a single hemophiliaentre in Pavia 61
Renal diseases in haemophilic patients: pathogenesis and clinical management. 61
Malattia di von Willebrand acquisita in 2 pazienti con malattia infiammatoria cronica intestinale 61
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 60
Valutazione dell'artropatia in soggetti affetti da emofilia. 60
Defective anticoagulation system in patients with previous myocardial infarction and residual angina 58
The behaviour of physiologic and acquired anticoagulants in patients with hyperhomocysteinemia and thrombotic complications 58
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. 58
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 58
Homocysteine plasma levels and vascular damage in congenital clotting factor deficiencies 58
Performance in sports of children and adolescents with hereditary bleeding disorders 57
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. 57
Treatment of bleeding episodes in acquired haemophilia with activated prothrombin complex concentrate: what is the optimal therapy? 57
Influenza del polimorfismo C677T del gene della MTHFR sui livelli di omocisteina plasmatici e sul rischio trombotico 56
Prevalenza di trombosi arteriose e venose in presenza delle mutazioni G20210A del gene della protrombina e R506Q del gene del FV (Leiden) 55
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 55
Thrombotic markers and mitral valve prolapse in migraine with and without aura at childhood onset 54
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study. 54
Acquired von Willebrand syndrome in inflammatory bowel disease 54
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 54
Imbalance of oxidant and antioxidant mechanism in ischaemic heart diseases 53
Mitral valve prolapse and prothrombotic risk factors in children and adolescents with migraine with aura and other idiopathic headaches 53
La valutazione della qualità della vita e della artropatia nel paziente emofilico adulto. 53
Von Willebrand factor/factor VIII behaviour and haemorrhagic manifestations in patients with neurofibromatosis type I 52
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy. 52
Castleman's disease with coagulation defect. A case report. 51
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 50
Prolonged aPTT occasionally detected in children before adenotonsillectomy and bleeding disorders 50
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 49
Impaired expression of dipeptidylaminopeptidase IV (DAPN)/CD26 in lymphocytes of hemophiliacs 49
Haemarthroses and arthropathy in mild/moderate haemophilia: data collected from a single Haemophilia Centre, Pavia, Italy 49
Expression of dipeptidylaminopeptidase IV-CD26 in circulating lymphocytes of homophilic subjects 48
Platelet function after in vivo and in vitro treatment with thrombolytic agents 48
Normalization of homocysteine plasma levels improves the physiological anticoagulation in patients with thromboembolic diseases 48
Treatment and progression of liver damage in HCV+ haemophiliacs: over 15 years follow up 47
THROMBOPHILIC SCREENING IN TURNER SYNDROME. 47
Clotting alterations in primary systemic amyloidosis 47
Bleeding tendency of unknown origin and protein Z levels. 45
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. 43
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 43
Risk factors of thrombosis in poorly controlled inflammatory bowel diseases: benefecial effect of LMW heparin as adjuvant therapy 42
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study 42
Long-term follow up in Acquired Hemophilia A: clinical courses and outcomes observed in a single Hemophilia Centre 41
Modalità di diagnosi e caratteristiche cliniche della M di von Willebrand acquisita 41
Thromboembolic disease and thrombotic risk factors: The effect of treating Hìhyperhomocysteinemia on physiological anticoagulation 39
HEPARIN INFUSION FACILITATES PLATELETS ACTIVABILITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WHO HAVE UNDERGONE THROMBOLYTIC THERAPY 38
Two years prophylaxis with FEIBA and inhibitors levels in a high responder haemophilic patient 36
Homocysteine, vitamin b12 and folic acid levels in psoriasi patients and correlation with disease severity. 36
Ruolo patogenetico delle alterazioni emocoagulative nell'insorgenza di s poliabortiva e di patologie ostetriche 34
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 33
Menometrorrhagia in adolescents: is it the first expression of congenital defects of hemostasis 32
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. 32
Platelet aggregation in platelet rich plasma and whole blood in 18 patients affected by agnogenic myeloid metaplasia 31
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study 30
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants 29
Haemostasis and low molecular weight heparin (LMWH) therapy in chronic inflammatory bowel diseases (IBD) not responsive to conventional therapy. 29
Interobserver reliability of ultrasound assessment of haemophilic arthropathy: Radiologist vs. non-radiologist 28
Plasma exchange and immunosuppressive therapy in a case of mild haemophilia A with inhibitors and a life-threatening lower limb haemorrhage. 27
Homocysteine and liver steatosis in HCV infected haemophiliacs 25
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. 25
Preoperative bleeding risk assessment with ISTH-BAT and laboratory tests in patients undergoing elective surgery: A prospective cohort study 2
Totale 4.875
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020304 0 0 0 0 0 68 23 69 4 93 44 3
2020/2021583 74 53 18 60 2 77 5 94 15 90 77 18
2021/2022418 12 0 13 9 3 10 13 20 33 13 50 242
2022/20231.270 146 85 2 111 148 137 0 62 508 17 35 19
2023/2024363 67 51 18 31 48 81 0 34 5 10 14 4
2024/2025238 15 97 25 33 21 47 0 0 0 0 0 0
Totale 4.875